Paper37684152
Hiding in plain sight: an epitope-based strategy for a subunit malaria vaccine.
Good MF and 1 other. Trends Parasitol, 2023. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Hiding in plain sight: an epitope-based strategy for a subunit malaria vaccine. Papers, record 37684152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37684152
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Review, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Malaria Vaccines | Major topic |
| Epitopes | Major topic |
| Vaccines, Subunit | Major topic |
| Humans | |
| Malaria | |
| Animals | |
| Antigens, Protozoan | |
| Plasmodium |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AI150944 | NIAID NIH HHS | United States | R01AI150944 | PubMed and NIH |
Source NIH RePORTER
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33947856 | Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial. | Nat Commun | 2021 | https://conductscience.org/library/papers/33947856 | PubMed |
| 2 | 36383682 | The RTS,S malaria vaccine: Current impact and foundation for the future. | Sci Transl Med | 2022 | https://conductscience.org/library/papers/36383682 | PubMed |
| 3 | 1928564 | Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. | Am J Trop Med Hyg | 1991 | https://conductscience.org/library/papers/1928564 | PubMed |
| 4 | 34355693 | The need for practical insecticide-resistance guidelines to effectively inform mosquito-borne disease control programs. | Elife | 2021 | https://conductscience.org/library/papers/34355693 | PubMed |
| 5 | 35835738 | Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria. | Nat Commun | 2022 | https://conductscience.org/library/papers/35835738 | PubMed |
| 6 | 20098724 | The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis. | PLoS Med | 2010 | https://conductscience.org/library/papers/20098724 | PubMed |
| 7 | 25075834 | Spread of artemisinin resistance in Plasmodium falciparum malaria. | N Engl J Med | 2014 | https://conductscience.org/library/papers/25075834 | PubMed |
| 8 | 11920300 | A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. | J Infect Dis | 2002 | https://conductscience.org/library/papers/11920300 | PubMed |
| 9 | 7520963 | Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. | Lancet | 1994 | https://conductscience.org/library/papers/7520963 | PubMed |
| 10 | 33964223 | Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. | Lancet | 2021 | https://conductscience.org/library/papers/33964223 | PubMed |
| 11 | 33854065 | Accelerated phase Ia/b evaluation of the malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of humoral immune responses. | NPJ Vaccines | 2021 | https://conductscience.org/library/papers/33854065 | PubMed |
| 12 | 24176554 | Escaping the immune system: How the malaria parasite makes vaccine development a challenge. | Trends Parasitol | 2013 | https://conductscience.org/library/papers/24176554 | PubMed |
| 13 | 21916638 | A field trial to assess a blood-stage malaria vaccine. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21916638 | PubMed |
| 14 | 21916656 | Protection against malaria by MSP3 candidate vaccine. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21916656 | PubMed |
| 15 | 35130487 | Multi-Dose Priming Regimens of PfSPZ Vaccine: Safety and Efficacy against Controlled Human Malaria Infection in Equatoguinean Adults. | Am J Trop Med Hyg | 2022 | https://conductscience.org/library/papers/35130487 | PubMed |
| 16 | 35103596 | A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates. | Elife | 2022 | https://conductscience.org/library/papers/35103596 | PubMed |
| 17 | 29736269 | Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy. | NPJ Vaccines | 2018 | https://conductscience.org/library/papers/29736269 | PubMed |
| 18 | 8958044 | Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. | Immunology | 1996 | https://conductscience.org/library/papers/8958044 | PubMed |
| 19 | 30630936 | High-density Peptide Arrays Help to Identify Linear Immunogenic B-cell Epitopes in Individuals Naturally Exposed to Malaria Infection. | Mol Cell Proteomics | 2019 | https://conductscience.org/library/papers/30630936 | PubMed |
| 20 | 11226296 | The surface variant antigens of Plasmodium falciparum contain cross-reactive epitopes. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11226296 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40900278 | Designing a multi-epitope vaccine against the midgut-specific fibrinogen-related protein 1(FREP1) of Anopheles stephensi to enhance protection against the malaria parasite: a step beyond traditional vaccine development approaches. | Biotechnol Lett | 2025 | https://conductscience.org/library/papers/40900278 | PubMed |
| 40234440 | Recent perspectives in clinical development of malaria vaccines. | Nat Commun | 2025 | https://conductscience.org/library/papers/40234440 | PubMed |
| 39921669 | Protection acquired upon intraperitoneal group a Streptococcus immunization is independent of concurrent adaptive immune responses but relies on macrophages and IFN-γ. | Virulence | 2025 | https://conductscience.org/library/papers/39921669 | PubMed |
| 38842304 | Detection of naturally acquired, strain-transcending antibodies against rosetting Plasmodium falciparum strains in humans. | Infect Immun | 2024 | https://conductscience.org/library/papers/38842304 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37684152
GET https://conductscience.org/api/papers/v1/37684152/references?page=2